Richard Russo is President & CEO of the Company and also a board member. Richard is a veteran of the Medtech space and has been successful in both corporate and start-up firms. Prior to joining to joining Endomedix, Richard was the CEO of a French start-up, OST Développement SA (subsidiary of Osteotech, a NASDAQ firm). Starting with a base of virtually no customers, OST quickly built up a $20+M business by pioneering a new concept product in Europe, Latin America & Asia. The company was subsequently acquired by Medtronic. Richard was also a seed investor and manager (clinical research & regulatory affairs) in a Medtech start-up, Meditron which successfully developed and commercialize a Class III device and was acquired by Cross Medical. Richard has also worked at major public firms such as American Hospital Supply (now Baxter International), CR Bard, Electro-Biology (now Biomet) and American Sterilizer in a marketing, strategic planning and business development, sales, clinical research and regulatory affairs leadership roles. He has demonstrated strength in new product development and in clinical research & regulatory affairs by successfully commercializing new products and obtaining regulatory approvals including two PMA’s and CE mark for Class III devices. He was chair of the Governmental Affairs Committee for the human tissue industry group during FDA’s development of regulations for this sector. Since joining Endomedix in 2009, Richard has revised the Company’s business model and technical direction and re-established its laboratory and product development team, leading to the creation of a novel platform technology with 8 issued patents. He has also become the Company’s lead investor. Richard earned a BA cum laude at Boston College and a MBA at Columbia Business School.
John M Abrahams, MD, MS
Co-Founder and Board Member
JOHN M. ABRAHAMS, MD is Associate Professor of Neurological Surgery at New York Medical College, Westchester Medical Center, a Level 1 Trauma Center. He is also Assistant Professor at Albert Einstein College of Medicine, Montefiore Medical center. Within the practice of neurosurgery, Dr. Abrahams has a focus on intracranial surgery and brain tumors. He is the founder of the Westchester Neuroscience Research Foundation to research malignant brain tumors, stroke and spinal cord injuries. Dr. Abrahams has authored over 25 peer-reviewed articles and book chapters. He has received the Galbraith Award for Research in Cerebrovascular Surgery from the Congress of Neurological Surgeons and other awards.
Dr. Abrahams received a BS in Physics from LeMoyne College and a MS degree in Biomedical Engineering from Rensselaer Polytechnic Institute. He received his medical degree from New Medical College and performed his Residency in Neurosurgery at University of Pennsylvania. Dr. Abrahams completed both a Spine Fellowship and a Research Fellowship at the Hospital of the University of Pennsylvania. Dr. Abrahams is a practicing neurosurgeon at 3 NYC area hospitals and is president of Brain and Spine Surgeons of New York.
James. R. Pastena
JAMES R PASTENA is a medical device executive with 35+ years in the orthopaedic and spinal/neurosurgical sectors. Jim is currently Chairman and President of Precision Spine LLC, a privately held spinal implant firm located in New Jersey. He is also a board member of Paradigm Spine LLC. Jim was previously CEO of electroCore LLC, a medical device start-up firm developing vagus nerve stimulation devices, and was president of EBI Medical Systems division of Biomet, Inc. from 1983 – 2010 where he was responsible for the development and management of the bone growth stimulation and spinal implant businesses. Jim is a graduate of Farleigh Dickinson University.
Weiliam Chen, Ph.D, RPH
Co-Founder and Board Member
WEILIAM CHEN, Ph.D., RPh. has 20 years of research experience in both university-based research centers and associated private research groups. He previously held academic appointments at the University of Michigan Medical School, University of Pennsylvania School of Medicine/Children’s Hospital of Philadelphia, SUNY-Stony Brook Department of Biomedical Engineering, and New York University School of Medicine. In addition to co-founding Endomedix, Inc., Dr. Chen is a co-founder of Sustained Nano Systems, LLC, a firm using nanovector and microvector components to enhance drug delivery. Dr. Chen is the Principal Investigator for the 7 NIH-funded SBIR grants awarded to date to Endomedix, with a total value of $2.8 million. Dr. Chen also serves on many national and international grant review panels including the National Institutes of Health, the Department of Defense, the Science Foundation of Ireland, UK Medical Research Council, Israel Science foundation, and Portugal Fundação para a Ciência e a Tecnologia.
Dr. Chen earned a BS in Pharmacy from the University of Wisconsin-Madison, a MS and a PH.D in Pharmaceutics from the University of Michigan-Ann Arbor, and held a post-doctoral fellowship in pediatric cardiology at the University of Michigan Medical Center.
Richard A. Olson
RICHARD OLSON is a veteran of the pharmaceutical and consumer health sectors. He served as Vice President of Richardson-Vicks in the Vick Americas/Far East Division and in the Vick Health Care Division. Dick later served as Executive Vice President Fisons Consumer Health USA and as Vice President of Business Development for Schering-Plough Healthcare Products. He has been an advisor and consultant to several early stage companies in the analgesics, diagnostics and women’s health sectors.
Dick earned a B.Sc in Industrial and Labor Relations and also an MBA, both at Cornell University.